GoodmanL., and GillmanA.: The Pharmacological Basis of Therapeutics, New York: MacMillan Co., 1965, p 404.
2.
RauchS., and MccleveD.: Physiopathology of Neural and Humoral Regulation of the Salivary Glands, Int Dent J11: 376–395, 1961.
3.
PohtoP., and PaasonerM.K.: Studies on Salivary Gland Hypertrophy Induced in Rats by Isoprenaline, Acta Pharmacol Toxicol29: 45–50, 1964.
4.
OhlinP.: Isoprenaline as a Secretory Agent in Salivary Glands, Acta Univ Lund11: 3–8, 1964.
5.
ShimamotoK., and InoueK.: Mode of the Sympathetic Innervation of the Salivary Glands in Dogs, Jap J Pharmacol7: 78–93, 1958.
6.
EmmelinN., and HolmbergJ.: The Presence of Beta-Receptors in the Submaxillary Gland of the Dog, Br J Pharmacol30: 371–378, 1967.
7.
ZengoA.N.; MandelI.D.; SolomonA.; and BlockP.: Chemistry of Rat Saliva Following Isoproterenol Administration, J Oral Ther Pharmacol4: 359–363, 1968.
8.
MandelI.D., and KatzR.: The Effect of Pharmacologic Agents on Salivary Secretion and Composition. II. Isoproterenol Alpha and Beta Adrenergic Blockers, J Oral Ther Pharmacol4: 260–269, 1968.
9.
KatzR., and MandelI.D.: Action and Interaction of Isoproterenol and Alpha and Beta Adrenergic Blockers in Parotid and Submaxillary Secretions in Man, Proc Soc Exp Biol Med128: 1140–1145, 1968.
10.
CarawayW.T.: A Stable Starch Substance for the Determination of Amylase in Serum and Other Body Fluids, Am J Clin Pathol32: 91–93, 1959.
11.
RabatE.A., and MayerM.M.: Experimental Immunochemistry, Springfield, Ill.: Charles C Thomas, 1961, p 559.
12.
KabatE.A., and MayerM.M.: Experimental Immunochemistry, Springfield, Ill.: Charles C Thomas, 1948, p 321.
13.
SimsonJ.: Discharge and Restitution of Secretory Material in the Rat Parotid Gland in Response to Isoproterenol, Z Zellforsch Mikrosk Anat101: 175–191, 1969.
LandsA.M.; ArnoldA.; McauliffJ.P.; LuduenaF.P.; and BrownT.G.: Differentiation of Receptor Systems Activated by Sympathomimetic Amines, Nature214: 597–598, 1967.
16.
MandelI.D., and KatzR.L.: Effect of Pilocarpine and a Beta Adrenergic Blocking Agent on Human Saliva, Pharmacol Ther Dent1: 71–81, 1971.
17.
FormgrenH.: A Clinical Comparison of the Effect of Oral Terbutaline and Orciprenaline, Scand J Respir Dis51: 195–202, 1970.
18.
GlassP., and DulfanoM.J.: Evaluation of a New B2 Adrenergic Receptor Stimulant, Terbutaline in Bronchial Asthma. I. Subcutaneous Comparison with Epinephrine, Curr Ther Res15: 141–149, 1973.
